Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 22, 2018

View Archived Issues

Uncovering the regulatory role of a prognostic microRNA in pancreatic ductal adenocarcinoma

Study finds nitrated meat products are associated with mania-like hyperactivity

Angiotensin II activates a macrophage-to-sensory neuron crosstalk in peripheral pain sensitization

One protein affects translation of multiple autism risk genes

GNE-684: a potent inhibitor of RIPK1 for treating inflammatory diseases due to dysregulated NEMO

Viela Bio initiates first-in-human study of VIB-9600

Amgen initiates first-in-human studies with AMG-424 and AMG-397

Ichor announces utilization of TriGrid delivery system in a phase I/IIb study of GX-188E vaccine

ProMIS Neurosciences reports positive results for PMN-310 in Alzheimer's disease

GNE-616: a promising non-opioid drug candidate for the treatment of Nav1.7-mediated pain

Lixte partners with Moffitt for phase Ib/II study of LB-100 in low and intermediate-1 risk MDS

Boehringer Ingelheim discovers new FFAR1 agonists

At ACS national meeting, researchers share their successes

Sihuan initiates phase II trial with anaprazole in China

New LRRK2 inhibitors patented by GlaxoSmithKline

UCB presents alpha-synuclein aggregation inhibitors

Sun Pharma Advanced Research Co. identifies estrogen receptor antagonists

Araxes Pharma patents KRAS inhibitors

Ono announces new Japanese approvals for Opdivo

Hanmi Science synthesizes new protein kinase inhibitors

Biosceptre initiates phase I trial with peptide cancer vaccine BIL-06v

Berlin Cures completes phase I study of BC-007 for cardiomyopathy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...